These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35381761)

  • 21. Cetuximab Responses in Patients with HNSCC Correlate to Clonal Expansion Feature of Peripheral and Tumor-Infiltrating T Cells with Top T-Cell Receptor Clonotypes.
    Ge H; Ferris RL; Wang JH
    Clin Cancer Res; 2023 Feb; 29(3):647-658. PubMed ID: 36315045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
    Nguyen N; Bellile E; Thomas D; McHugh J; Rozek L; Virani S; Peterson L; Carey TE; Walline H; Moyer J; Spector M; Perim D; Prince M; McLean S; Bradford CR; Taylor JM; Wolf GT;
    Head Neck; 2016 Jul; 38(7):1074-84. PubMed ID: 26879675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-Infiltrating Lymphocytes in Patients With Advanced Laryngeal Cancer Undergoing Bioselection.
    Heft Neal ME; Smith JD; Birkeland AC; Haring CT; Chinn SB; Shuman AG; Casper KA; Malloy KM; Stucken CL; Mclean SA; Rosko AJ; Mierzwa ML; Shah J; Schonewolf C; Swiecicki PL; Worden FP; Wolf GT; Bradford CR; Prince MEP; Brenner JC; Spector ME
    Otolaryngol Head Neck Surg; 2022 Mar; 166(3):498-505. PubMed ID: 34030495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms.
    Ruffini E; Asioli S; Filosso PL; Lyberis P; Bruna MC; Macrì L; Daniele L; Oliaro A
    Ann Thorac Surg; 2009 Feb; 87(2):365-71; discussion 371-2. PubMed ID: 19161739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.
    Poropatich K; Hernandez D; Fontanarosa J; Brown K; Woloschak G; Paintal A; Raparia K; Samant S
    J Oral Pathol Med; 2017 Nov; 46(10):972-978. PubMed ID: 28632936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer.
    Junker N; Andersen MH; Wenandy L; Dombernowsky SL; Kiss K; Sørensen CH; Therkildsen MH; Von Buchwald C; Andersen E; Straten PT; Svane IM
    Cytotherapy; 2011 Aug; 13(7):822-34. PubMed ID: 21428850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
    Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
    Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8
    Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A
    J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor Infiltrating Lymphocytes and CD8+ T Cell Subsets as Prognostic Markers in Patients with Surgically Treated Laryngeal Squamous Cell Carcinoma.
    Chatzopoulos K; Kotoula V; Manoussou K; Markou K; Vlachtsis K; Angouridakis N; Nikolaou A; Vassilakopoulou M; Psyrri A; Fountzilas G
    Head Neck Pathol; 2020 Sep; 14(3):689-700. PubMed ID: 31749124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An algorithm for standardization of tumor Infiltrating lymphocyte evaluation in head and neck cancers.
    Xirou V; Moutafi M; Bai Y; Nwe Aung T; Burela S; Liu M; Kimple RJ; Shabbir Ahmed F; Schultz B; Flieder D; Connolly DC; Psyrri A; Burtness B; Rimm DL
    Oral Oncol; 2024 May; 152():106750. PubMed ID: 38547779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histogram parameters derived from T1 and T2 weighted images correlate with tumor infiltrating lymphocytes and tumor-stroma ratio in head and neck squamous cell cancer.
    Meyer HJ; Höhn AK; Surov A
    Magn Reson Imaging; 2021 Jul; 80():127-131. PubMed ID: 33971242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.
    Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N
    J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma.
    Hu C; Tian S; Lin L; Zhang J; Ding H
    Oral Oncol; 2020 Mar; 102():104560. PubMed ID: 31923855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The integration of proportion and cell counts of stromal, not intratumoral, PD-1+ tumor-infiltrating lymphocytes has prognostic significance in esophageal squamous cell carcinoma.
    Song Q; Shi F; Xiao S; Li Y; Zhao Y; Chang H
    Dis Esophagus; 2021 Jan; 34(1):. PubMed ID: 32395761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The landscape of immune microenvironment in lung adenocarcinoma and squamous cell carcinoma based on PD-L1 expression and tumor-infiltrating lymphocytes.
    Chen L; Cao MF; Zhang X; Dang WQ; Xiao JF; Liu Q; Tan YH; Tan YY; Xu YY; Xu SL; Yao XH; Cui YH; Zhang X; Bian XW
    Cancer Med; 2019 Dec; 8(17):7207-7218. PubMed ID: 31605439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overall assessment of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: time to take notice.
    Almangush A; Leivo I; Mäkitie AA
    Acta Otolaryngol; 2020 Mar; 140(3):246-248. PubMed ID: 32022615
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer.
    Ahn S; Chung YR; Seo AN; Kim M; Woo JW; Park SY
    PLoS One; 2020; 15(5):e0233037. PubMed ID: 32401825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations Between ADC and Tumor Infiltrating Lymphocytes, Tumor-Stroma Ratio and Vimentin Expression in Head and Neck Squamous Cell Cancer.
    Meyer HJ; Höhn AK; Surov A
    Acad Radiol; 2022 Mar; 29 Suppl 3():S107-S113. PubMed ID: 34217611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Head and Neck Squamous Cell Carcinoma.
    Xu Q; Wang C; Yuan X; Feng Z; Han Z
    Transl Oncol; 2017 Feb; 10(1):10-16. PubMed ID: 27888708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer.
    Balermpas P; Michel Y; Wagenblast J; Seitz O; Weiss C; Rödel F; Rödel C; Fokas E
    Br J Cancer; 2014 Jan; 110(2):501-9. PubMed ID: 24129245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.